Avantax Advisory Services, Inc. Ptc Therapeutics, Inc. Transaction History
Avantax Advisory Services, Inc.
- $16 Billion
- Q1 2025
A detailed history of Avantax Advisory Services, Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 9,104 shares of PTCT stock, worth $403,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,104
Previous 9,104
-0.0%
Holding current value
$403,671
Previous $410,000
12.93%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PTCT
# of Institutions
287Shares Held
78.8MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$382 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$345 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$332 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$241 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$240 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.17B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...